IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells
Wang, J; Liu, XY; Jiang, W
关键词a(549) And a(549)(Ddp) Cell Lines Drug Resistance Apoptosis Lung Neoplasms Antisense S-oligodeoxynucleotide
刊名CHINESE MEDICAL JOURNAL
2000-10-01
113期:10页:957-960
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]PROTEIN MRP ; OLIGONUCLEOTIDES ; INHIBITION ; EXPRESSION ; APOPTOSIS
英文摘要

Objective To detect the influence of antisense s-oligodeoxynucleotides (S-ODNs) of bd-2 and multidrug resistance-associated protein (MRP) genes multidrug resistance-associated protein gene and bcl-2 antisense S-oligodeoxynucleotides on cisplatin-resistant lung adenocarcinoma cell line A(549)(DDP) which overexpresses both bcl-2 and MRP.

Methods A549DDP cells were treated with sense and antisense S-ODN mediated by lipofection. Expression of MRP and bcl-2 mRNA and protein in the treated cells was measured by RT-PCR and flow cytometry (FCM), respectively. Apoptosis was identified by DNA electrophoresis and terminal deoxynucleotidyl transferase (TdT)-mediated biotin dUTP nick end-labeling(TUNEL). The degree of drug resistance of the treated cells was detected by a cell viability 3′-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl-tefrazolium bromide thiazolylblue (MTT) assay.

Results Expression of bcl-2 and MRP significantly decreased in the cells treated with bcl-2 or/and MRP antisense S-ODN for 48h as compared to the cells untreated and sense-treated (P < 0.05). Resistance to cisplatin in the cells treated with bcl-2 or/and MRP antisense S-ODN decreased by 60.6% (6.5 times), 56.4% (7.2 times) and 71.0% (4.8 times), respectively, which paralleled the decrease of bcl-2 and MRP expression. Similarly, the resistance to etoposide and epirubicin in antisense-treated cells also reduced in parallel to decreases of the two gene expressions. The drug resistance in sense-treated cells was similar to that in untreated cells. Statistically significant dose-and concentration-dependent increases of apoptotic cells were observed in the groups exposed to 100 mu mol/L cisplatin for 48 h after treatment by bcl-2 or/and MRP antisense.

Conclusion Bcl-2 and MRP were at least additive and possibly synergistic in conferring drug resistance in a cisplatin-resistant lung adenocarcinoma cell line. Antisense S-ODN could attenuate drug resistance by promoting cells apoptosis, which might lead to a new treatment for patients with non-small cell lung cancers (NSCLCs) who are refractory to conventional chemotherapy.

语种英语
WOS记录号WOS:000089840800020
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52198
专题北京大学临床肿瘤学院
北京大学基础医学院
作者单位Beijing Med Univ, Sch Oncol, Dept Internal Med, Beijing 100036, Peoples R China
推荐引用方式
GB/T 7714
Wang, J,Liu, XY,Jiang, W. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells[J]. CHINESE MEDICAL JOURNAL,2000,113(10):957-960.
APA Wang, J,Liu, XY,&Jiang, W.(2000).Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.CHINESE MEDICAL JOURNAL,113(10),957-960.
MLA Wang, J,et al."Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells".CHINESE MEDICAL JOURNAL 113.10(2000):957-960.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Co-transfection of M(381KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, J]的文章
[Liu, XY]的文章
[Jiang, W]的文章
百度学术
百度学术中相似的文章
[Wang, J]的文章
[Liu, XY]的文章
[Jiang, W]的文章
必应学术
必应学术中相似的文章
[Wang, J]的文章
[Liu, XY]的文章
[Jiang, W]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。